Expression of EphB2 in gastric carcinoma and the correlation with metastasis

GAO Yun-shu,YU Guan-zhen,CHEN Ying,WANG Jie-jun

DOI: https://doi.org/10.3969/j.issn.1009-0460.2008.08.007

2008-01-01

Chinese Clinical Oncology

Abstract:Objective:The receptor tyrosine kinase EphB2 has recently been shown to be a direct transcriptional target of TCF/beta-catenin.To detect the expression of EphB2 in the tumor tissues of primary gastric carcinoma as well as lymphatic and visceral metastases and to investigate their roles in tumorigenesis and metastasis,and gastric cancer clinical pathology parameters of the relationship.Methods:The protein expression of EphB2 in normal mucosatissues(n=71),primary tumors(n=71),lymp haticmetastases(n=71),and distant visceral metastases(n=26)were examined by immunohistochemical staining and tissue microarray.The difference between primary tumor and normal tissue as well as primary tumor and matched metastases were compared.Results:The positive rate of EphB2 decreased gradually accompanied with the tumor development.Immunohistochemical staining revealed down-regulated expression of EphB2 in lymph node and visceral metastases.Positive rates of EphB2 expression in normal tissues,primary tumor tissues,lymph node and visceral metastases were 83.1%(59/71),60.6(43/71),43.7%(31/71)and 26.9%(7/26).EphB2 expression was significantly higher in normal tissues than that in primary tumor tissues(P<0.01).It was significantly lower in lymph node and visceral metastases than that in primary tumor tissues(P=0.003).Primary tumors and metastases in EphB2 expression exist in the case and gender(male)and highly relevant to the depth of invasion.(P<0.05).Conclusion:Tumor metastasis results from gradual accumulation of abnormal genetic alterations.Down-regulation of EphB2 play a critical role in metastasis of gastric carcinoma.